MedPath

Study of Blood Samples From Patients With Ewing Sarcoma and Their Relatives

Completed
Conditions
Sarcoma
Registration Number
NCT01210209
Lead Sponsor
Institut Curie
Brief Summary

RATIONALE: Studying samples of blood in the laboratory from patients with cancer and their relatives may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples collected from patients with Ewing sarcoma and their relatives.

Detailed Description

OBJECTIVES:

* To identify and characterize a genetic susceptibility factor to Ewing's sarcoma by performing a Genome-Wide Association Study with as many as possible Ewing sarcoma patients.

OUTLINE: This is a multicenter study.

Blood samples are collected from patients and their relatives. Blood DNA samples are analyzed for susceptibility genes of Ewing Sarcoma.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
350
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification and characterization of susceptibility genes in patients with Ewing sarcomaThrough study completion, an average of 10 years

Identification and characterization of susceptibility genes in patients with Ewing sarcoma

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Curie Hopital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath